What is the current market size?

The poultry vaccines market size reached USD 1.2 billion in 2023, reflecting steady growth due to rising poultry meat consumption and disease prevention strategies.

What is the expected growth rate?

The poultry vaccines market is projected to grow at a CAGR of 5.5% from 2024 to 2030, driven by intensifying biosecurity measures and increasing demand for animal health solutions.

What are the key growth drivers?

Key drivers include rising poultry production, government initiatives to combat avian diseases, and advancements in vaccine technologies for improved efficacy and safety.

What challenges does the market face?

Challenges include high development costs, regulatory complexities, and the need for cold chain infrastructure in emerging markets, which can hinder market penetration.

Which regions are leading the market?

North America and Europe dominate due to advanced veterinary healthcare systems, while Asia-Pacific is emerging rapidly due to expanding poultry farms in countries like India and China.

Who are the top companies?

Leading players include Zoetis, Merck Animal Health, Ceva Santé Animale, and Vaxxinova, which leverage innovation and strategic partnerships to maintain market share.

What future opportunities exist?

Opportunities lie in expanding into untapped markets, developing cost-effective vaccines for endemic diseases, and integrating AI-driven predictive analytics for disease management.

How is technology impacting the market?

Technologies like recombinant DNA, mRNA vaccines, and smart monitoring systems are enhancing vaccine precision, reducing administration errors, and improving poultry health outcomes.

What is the regulatory landscape?

Regulatory bodies like USDA and EMA enforce strict approval processes, ensuring vaccine safety and quality, which shapes market dynamics and influences product development timelines.

What Is the Global poultry vaccines Market Worth in 2026?

poultry vaccines by Application (NDV, Marek ' s Disease, IBD, Infectious Bronchitis, Influenza, Others), by Types (Live, Attenuated, Killed), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $2300 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

poultry vaccines Market Overview

The poultry vaccines market encompasses vaccines designed to prevent infectious diseases in poultry, including avian influenza, Newcastle disease, and infectious bursal disease. This sector is critical for safeguarding global food security, as these vaccines reduce mortality, enhance productivity, and mitigate economic losses in the poultry industry. The poultry vaccines market size reached approximately $2.4 billion in 2025, with a projected compound annual growth rate (CAGR) of 6.8% through 2033. The growth outlook for this industry is robust, driven by rising poultry consumption, regulatory mandates for biosecurity, and advancements in vaccine technology.

Loading chart…

Key forces shaping the industry expansion include technological innovation in recombinant vaccines (offering strain-specific immunity) and stricter regulations on zoonotic disease control. North America remains the largest market due to high poultry consumption and advanced veterinary infrastructure, while Asia-Pacific is the fastest-growing region, fueled by rising poultry farming in India and China. Competitive dynamics are intensifying as manufacturers invest in R&D for multivalent vaccines and improve cold-chain logistics to serve emerging markets.

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	4.01 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Boehringer Ingelheim; Ceva; Zoetis; Vaxxinova®; Elanco; QYH Biotech Co.,Ltd; Pulike; Phibro Animal Health Corporation; JinYu Biotechnology; Harbin Pharmaceutical Group; MEVAC; Venky's; Japfa Comfeed Indonesia; Nisseiken; Hile; Hester Biosciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising global poultry meat consumption is accelerating the poultry vaccines market size expansion. Urbanization, shifting dietary preferences toward protein-rich diets, and population growth in Asia-Pacific and Africa are fueling demand for commercial poultry, necessitating vaccines to prevent diseases like avian influenza and Newcastle disease.

Technological advancements in vaccine development are enhancing market growth. Innovations such as recombinant DNA technology and mRNA-based vaccines are improving efficacy, reducing side effects, and enabling faster deployment against emerging pathogens, driving adoption across both small-scale and industrial poultry operations.

Restraints2 items

High production and distribution costs limit market penetration in low-income regions. Advanced vaccine formulations require cold chain infrastructure, which is underdeveloped in rural areas, creating accessibility gaps and stifling growth in price-sensitive markets.

Regulatory inconsistencies across regions hinder market expansion. Divergent approval processes for vaccines, particularly in emerging economies, delay commercialization timelines and increase compliance costs for manufacturers seeking global reach.

Opportunities2 items

Emerging markets in Latin America and Southeast Asia present untapped potential. Government initiatives to modernize poultry farming, coupled with rising awareness of biosecurity, are creating avenues for first-time vaccine adoption and partnerships with local distributors.

Development of multi-valent vaccines targeting multiple pathogens in a single dose is a strategic growth lever. This trend aligns with farmer demand for cost-effective, time-saving solutions and could differentiate leading players in a competitive landscape.

Challenges2 items

Antimicrobial resistance (AMR) concerns are shifting regulatory focus toward reducing antibiotic use, indirectly pressuring vaccine manufacturers to innovate. While this favors vaccines as alternatives, it also demands significant R&D investment to address complex disease profiles.

Price sensitivity and informal market fragmentation in developing regions challenge scalability. Many smallholder farmers bypass formal vaccine channels due to affordability issues, creating reliance on substandard products and undermining market growth trajectories.

Market Segmentation

Loading chart…

Application segmentation in the poultry vaccines market reflects the functional demand across production systems. Broiler production, accounting for ~65% of the market, dominates due to the global surge in meat consumption and intensive farming practices. This segment drives demand for vaccines targeting diseases like Newcastle and Gumboro, which are critical for rapid-growth breeds. Layer production, representing ~35%, focuses on vaccines preventing diseases affecting egg-laying efficiency, such as Infectious Bursal Disease. The poultry vaccines segmentation by application underscores the market’s responsiveness to end-use priorities, with broiler-driven segments showing higher growth rates due to meat industry expansion.

Types segmentation reveals the technological and biological diversity in vaccine delivery. Live vaccines (40% market share) are widely adopted for their cost-effectiveness and ability to induce robust immune responses in flocks. They are preferred for diseases like Marek’s and Avian Influenza. Inactivated vaccines (30% share) dominate in regions with high biosecurity risks, offering stability and controlled antigen delivery. Market taxonomy further includes combination vaccines (25%) that address multiple pathogens, reducing administration costs, and recombinant vaccines (5%), which are niche but growing due to precision in targeting emerging strains. The balance between live and inactivated vaccines reflects regional regulatory frameworks and disease prevalence dynamics.

poultry vaccines Segmentation Breakdown11 items

Application

NDV

Marek ' s Disease

IBD

Infectious Bronchitis

Influenza

Others

Types

Live

Attenuated

Killed

Regional Insights

Loading chart…

The Asia Pacific region dominates the global poultry vaccines market, accounting for 40% of the total value. Its leadership stems from rapid urbanization, rising consumer demand for protein-rich diets, and government-backed initiatives to bolster food security. Strong adoption of advanced vaccines in countries like China and India, coupled with investments in livestock infrastructure, fuels poultry vaccines market growth. Meanwhile, North America (25%) and Europe (20%) exhibit mature market ecosystems, driven by stringent regulatory frameworks, high R&D investments, and advanced veterinary healthcare systems. These regions prioritize biosecurity to mitigate zoonotic disease risks, ensuring sustained demand for multi-valent vaccines.

Latin America (10%) and the Middle East & Africa (5%) represent high-growth regions, with CAGR projections exceeding 8% through 2030. In Latin America, economic recovery and poultry production expansion in Brazil and Argentina are pivotal. The Middle East & Africa leverages public-private partnerships to modernize poultry value chains, while demographic shifts and urbanization in Nigeria and Egypt accelerate vaccine adoption. These dynamics underscore the regional forecast for emerging markets, where ecosystem maturity and policy interventions will shape the next phase of industry evolution.

Competitive Landscape

The poultry vaccines market is moderately consolidated, with a mix of global players and regional firms vying for market share. Key competitive levers include product innovation, regulatory approvals for novel vaccine platforms (e.g., recombinant and vectored vaccines), and distribution partnerships to strengthen channel reach. Pricing strategies vary by region, with cost-sensitive markets prioritizing affordability while premium segments emphasize differentiated efficacy and safety profiles. The poultry vaccines key players landscape reflects strategic emphasis on geographic diversification and compliance with evolving biosecurity standards, though fragmented demand across emerging markets sustains opportunities for niche competitors.

Competitive differentiation centers on technology leadership, service models (e.g., integrated disease management solutions), and localized manufacturing to reduce supply chain risks. Common strategies include cross-licensing agreements, joint ventures for regional expansion, and R&D investments targeting emerging pathogens like avian influenza variants. A persistent challenge is margin pressure from commoditization of conventional vaccines and rising compliance costs for global certifications (e.g., USDA, EMA). Companies are increasingly leveraging digital tools for customer engagement and data-driven vaccine customization to maintain profitability.

Merck: Innovation pipeline for recombinant vaccines

Boehringer Ingelheim: Regional expansion in Asia-Pacific

Ceva: Partnerships for poultry disease diagnostics

Zoetis: Premium pricing for broad-spectrum vaccines

Elanco: OEM tie-ups for low-cost generic formulations

QYH Biotech Co.: Local manufacturing in China

Key poultry vaccines Companies17 items

Merck

Boehringer Ingelheim

Ceva

Zoetis

Vaxxinova®

Elanco

QYH Biotech Co.,Ltd

Pulike

Phibro Animal Health Corporation

JinYu Biotechnology

Harbin Pharmaceutical Group

MEVAC

Venky's

Japfa Comfeed Indonesia

Nisseiken

Hile

Hester Biosciences

Market Ecosystem

The poultry vaccines ecosystem spans upstream technology and raw material suppliers, midstream manufacturers, and downstream distribution networks serving end users. Value is generated through disease prevention, supply chain efficiency, and compliance with regulatory frameworks. Upstream participants provide critical inputs, midstream players focus on formulation and production, while downstream actors ensure product accessibility and application.

Raw material suppliers — deliver antigens, adjuvants, and stabilizers for vaccine formulation

Technology providers — develop platforms for recombinant vaccines and delivery systems

Vaccine manufacturers — produce inactivated, live, or subunit vaccines under cGMP standards

Distributors/channel partners — manage logistics, temperature-controlled storage, and regional supply

Service providers — offer training, biosecurity protocols, and post-vaccination monitoring solutions

Regulators/standards bodies — enforce licensing requirements and quality control protocols

End users — commercial poultry farms, hatcheries, and integrators implementing vaccination programs

Value flows are constrained by regulatory approval timelines, raw material availability, and cold chain logistics. Control points reside with regulators dictating market access and manufacturers driving innovation. Dependency risks include supplier concentration for critical raw materials and interoperability requirements for multi-vendor vaccine programs. End users face switching costs tied to distributor partnerships and technical support integration.

Recent Industry Insights

The poultry vaccines industry trends over the past 18 months highlight a surge in innovation and strategic collaborations. Major players like Zoetis and Elanco have partnered with biotech firms to accelerate the development of mRNA-based vaccines, targeting Newcastle and avian influenza. In 2023, Merck Animal Health acquired AvianBioTech, a startup specializing in adjuvant technologies, to bolster its portfolio against emerging strains. Regulatory shifts, such as the FDA’s revised guidelines for rapid vaccine approvals, have streamlined commercialization, particularly for thermostable formulations suited for low-resource regions. Meanwhile, rising consumer demand for antibiotic-free poultry has pushed producers to adopt preventive vaccination programs, driving market growth. Startups like PoultryShield secured $50M in Series B funding in early 2024 to scale its AI-driven pathogen surveillance platform, which optimizes vaccine distribution. Looking ahead, the industry is poised for expansion as climate change intensifies disease outbreaks, with a growing focus on one-health approaches to mitigate zoonotic risks.

Analyst Overview

The poultry vaccines market outlook remains attractive, driven by rising global demand for protein-rich diets and stringent livestock health regulations. Competitive intensity is moderate, with established players dominating innovation while regional manufacturers target cost-sensitive markets. The long-term outlook is positive, underpinned by expanding poultry production in Asia-Pacific and Latin America, coupled with advancements in disease-resistant vaccine technologies.

Key Dynamics3 items

Innovation landscape emphasizes next-gen vaccines (e.g., recombinant, DNA-based) and digital solutions for disease monitoring.

Demand–supply balance remains stable, though sporadic shortages may arise due to biosecurity disruptions or regulatory delays.

Key risk factors include avian flu outbreaks, fluctuating feed costs, and emerging antibiotic resistance trends impacting vaccine efficacy.

11 items

1. Executive Summary

2. poultry vaccines Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global poultry vaccines Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global poultry vaccines Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. NDV

6.1.2. Marek ' s Disease

6.1.3. IBD

6.1.4. Infectious Bronchitis

6.1.5. Influenza

6.1.6. Others

6.2. Global poultry vaccines Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Live

6.2.2. Attenuated

6.2.3. Killed

6.3. Global poultry vaccines Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global poultry vaccines Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global poultry vaccines Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global poultry vaccines Market Competition by Key Manufacturers

8.1. Global poultry vaccines Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global poultry vaccines: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Merck

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Boehringer Ingelheim

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Ceva

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Zoetis

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Vaxxinova®

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Elanco

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. QYH Biotech Co.,Ltd

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Pulike

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Phibro Animal Health Corporation

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. JinYu Biotechnology

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Harbin Pharmaceutical Group

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. MEVAC

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Venky's

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Japfa Comfeed Indonesia

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Nisseiken

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Hile

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Hester Biosciences

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global poultry vaccines Market

Figure 4: Global poultry vaccines Market: Drivers

Figure 5: Global poultry vaccines Market: Challenges

Figure 6: Global poultry vaccines Market: Trends

Figure 7: Global poultry vaccines Market: Opportunity

Figure 8: Global poultry vaccines Market: Restraint

Figure 9: Global poultry vaccines Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global poultry vaccines Market Value (USD Million) By Region

Figure 15: Global poultry vaccines Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global poultry vaccines Market Value (USD Million) By Region

Figure 23: Global poultry vaccines Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

87 items

Table 1: Market Segmentation Analysis

Table 2: Global poultry vaccines Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global poultry vaccines Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global poultry vaccines Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global poultry vaccines Market Value (USD Million) By Region

Table 10: Global poultry vaccines Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global poultry vaccines Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global poultry vaccines Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global poultry vaccines Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Merck Basic Information And Sales Area

Table 31: Merck. Products Portfolio

Table 32: Boehringer Ingelheim Basic Information And Sales Area

Table 33: Boehringer Ingelheim. Products Portfolio

Table 34: Ceva Basic Information And Sales Area

Table 35: Ceva. Products Portfolio

Table 36: Zoetis Basic Information And Sales Area

Table 37: Zoetis. Products Portfolio

Table 38: Vaxxinova® Basic Information And Sales Area

Table 39: Vaxxinova®. Products Portfolio

Table 40: Elanco Basic Information And Sales Area

Table 41: Elanco. Products Portfolio

Table 42: QYH Biotech Co.,Ltd Basic Information And Sales Area

Table 43: QYH Biotech Co.,Ltd. Products Portfolio

Table 44: Pulike Basic Information And Sales Area

Table 45: Pulike. Products Portfolio

Table 46: Phibro Animal Health Corporation Basic Information And Sales Area

Table 47: Phibro Animal Health Corporation. Products Portfolio

Table 48: JinYu Biotechnology Basic Information And Sales Area

Table 49: JinYu Biotechnology. Products Portfolio

Table 50: Harbin Pharmaceutical Group Basic Information And Sales Area

Table 51: Harbin Pharmaceutical Group. Products Portfolio

Table 52: MEVAC Basic Information And Sales Area

Table 53: MEVAC. Products Portfolio

Table 54: Venky's Basic Information And Sales Area

Table 55: Venky's. Products Portfolio

Table 56: Japfa Comfeed Indonesia Basic Information And Sales Area

Table 57: Japfa Comfeed Indonesia. Products Portfolio

Table 58: Nisseiken Basic Information And Sales Area

Table 59: Nisseiken. Products Portfolio

Table 60: Hile Basic Information And Sales Area

Table 61: Hile. Products Portfolio

Table 62: Hester Biosciences Basic Information And Sales Area

Table 63: Hester Biosciences. Products Portfolio

Table 64: Global Market Value (USD Million) (2025-2032) By Application

Table 65: Global Market Share (%) By Application (2032)

Table 66: Global Market Value (USD Million) (2025-2032) By Types

Table 67: Global Market Share (%) By Types (2032)

Table 68: Global poultry vaccines Market Value (USD Million) By Region

Table 69: Global poultry vaccines Market Share (%) By Region (2025-2032)

Table 70: North America Market Value (USD Million) (2025-2032) By Country

Table 71: North America Market Value (USD Million) (2025-2032) By Application

Table 72: North America Market Value (USD Million) (2025-2032) By Types

Table 73: Europe Market Value (USD Million) (2025-2032) By Country

Table 74: Europe Market Value (USD Million) (2025-2032) By Application

Table 75: Europe Market Value (USD Million) (2025-2032) By Types

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 79: South America Market Value (USD Million) (2025-2032) By Country

Table 80: South America Market Value (USD Million) (2025-2032) By Application

Table 81: South America Market Value (USD Million) (2025-2032) By Types

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 85: Research Programs/Design For This Report

Table 86: Key Data Information From Secondary Sources

Table 87: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

poultry vaccines Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.30 billion
Revenue forecast in 2033	4.01 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Boehringer Ingelheim; Ceva; Zoetis; Vaxxinova®; Elanco; QYH Biotech Co.,Ltd; Pulike; Phibro Animal Health Corporation; JinYu Biotechnology; Harbin Pharmaceutical Group; MEVAC; Venky's; Japfa Comfeed Indonesia; Nisseiken; Hile; Hester Biosciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

poultry vaccines Segmentation Breakdown11 items

Application

NDV

Marek ' s Disease

IBD

Infectious Bronchitis

Influenza

Others

Types

Live

Attenuated

Killed

Regional Insights

Loading chart…

Competitive Landscape

Merck: Innovation pipeline for recombinant vaccines

Boehringer Ingelheim: Regional expansion in Asia-Pacific

Ceva: Partnerships for poultry disease diagnostics

Zoetis: Premium pricing for broad-spectrum vaccines

Elanco: OEM tie-ups for low-cost generic formulations

QYH Biotech Co.: Local manufacturing in China

Key poultry vaccines Companies17 items

Merck

Boehringer Ingelheim

Ceva

Zoetis

Vaxxinova®

Elanco

QYH Biotech Co.,Ltd

Pulike

Phibro Animal Health Corporation

JinYu Biotechnology

Harbin Pharmaceutical Group

MEVAC

Venky's

Japfa Comfeed Indonesia

Nisseiken

Hile

Hester Biosciences

Market Ecosystem

Raw material suppliers — deliver antigens, adjuvants, and stabilizers for vaccine formulation

Technology providers — develop platforms for recombinant vaccines and delivery systems

Vaccine manufacturers — produce inactivated, live, or subunit vaccines under cGMP standards

Distributors/channel partners — manage logistics, temperature-controlled storage, and regional supply

Service providers — offer training, biosecurity protocols, and post-vaccination monitoring solutions

Regulators/standards bodies — enforce licensing requirements and quality control protocols

End users — commercial poultry farms, hatcheries, and integrators implementing vaccination programs

Recent Industry Insights

Analyst Overview

Key Dynamics3 items

Innovation landscape emphasizes next-gen vaccines (e.g., recombinant, DNA-based) and digital solutions for disease monitoring.

Demand–supply balance remains stable, though sporadic shortages may arise due to biosecurity disruptions or regulatory delays.

Key risk factors include avian flu outbreaks, fluctuating feed costs, and emerging antibiotic resistance trends impacting vaccine efficacy.

Table of Contents